NCT00474903View on ClinicalTrials.gov

Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus

PHASE2CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

June 30, 2011

Conditions
Barrett EsophagusEsophageal Cancer
Interventions
DRUG

acetylsalicylic acid

Given orally

DRUG

esomeprazole magnesium

Given orally

OTHER

placebo

Given orally

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00474903 - Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus | Biotech Hunter | Biotech Hunter